Form 4 for EYPT EyePoint, Inc.
Accepted 2023-12-07 00:00:00 ET · period of report 2023-12-05 · accession 0001840315-23-000007 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2023-12-07 | 2023-12-05+ | EYPT | Ocumension Therapeutics | Dir | S - Sale | $19.51 | -1.00M | 2.01M | -33% | -$19.51M |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | common stock | 2023-12-05 | S | D | 733,758 | $19.91 | 2,276,963 | D | — | — | |
| 2 | Common | common stock | 2023-12-06 | S | D | 266,242 | $18.41 | 2,010,721 | D | — | — |